Pinarbasi, ErgunPercin, Ferda E.Yilmaz, MeralAkgun, EgemenCetin, MeralCetin, Ali2019-07-272019-07-282019-07-272019-07-2820071341-80761447-0756https://dx.doi.org/10.1111/j.1447-0756.2007.00473.xhttps://hdl.handle.net/20.500.12418/10668Aim: To assess the association between human epoxide hydrolase exon 3 and 4 polymorphisms and pre-eclampsia by carrying out a case-control study in Turkish women. Methods: DNA was extracted from peripheral blood leukocytes, and genotype distribution of exon 3 and exon 4 of epoxide hydrolase gene (EPHX) was carried out in 271 patients and 155 controls. Results: There was no statistically significant difference in the distribution of genotypes between pre-eclampsia without HELLP and pre-eclampsia plus HELLP cases and controls for the exon 3 and 4 polymorphism of EPHX. However, we found a significant association between the predicted enzyme activity level and pre-eclampsia (P = 0.018). The distribution of subjects with predicted high, intermediate and low microsomal epoxide hydrolase enzyme (EPHX) activity were 23.2, 38.8 and 38% in cases and 12, 47.3 and 40.7% in controls, respectively. Conclusion: Although we could not find any association between genetic variability in exon 3 and 4 of EPHX and pre-eclampsia, genetic variability in these two exons jointly modifies the predicted enzyme activity and may be a risk factor for pre-eclampsia.en10.1111/j.1447-0756.2007.00473.xinfo:eu-repo/semantics/closedAccessgeneticmicrosomal epoxide hydrolasepolymorphismpre-eclampsiaArticle3313732172126632-s2.0-33845880410Q2WOS:000243023200004Q4